Anzeige
Mehr »
Login
Mittwoch, 27.05.2020 Börsentäglich über 12.000 News von 629 internationalen Medien
Pilz-Granate gibt Vollgas! Diese Aktie spielt in einer ganz anderen Liga!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiNovavax launches trial of coronavirus vaccine candidate
DiNew US approval for Takeda's Alunbrig
DiSanofi to sell stake in Regeneron
DiAstraZeneca links with ArcherDX to detect minimal residual disease in lung cancer patients
SaGov't unveils coronavirus antibody testing scheme
SaGov't invests £7m in patient recruitment centres for clinical research
SaGSK partners with Samsung to expand biopharma manufacturing
SaNICE u-turn backs Roche's Tecentriq for triple negative breast cancer
DoResearchers investigate impact of lockdown on musculoskeletal conditions
DoFirst UK healthcare worker to enrol in COVID-19 prevention trial
DoUK risks second surge of coronavirus without clarity on test, track and trace
DoAstraZeneca/MSD's Lynparza wins prostate cancer approval
20.05.Ergomed teams up with Automation Anywhere and DataRobot
20.05.New US nod for Roche's Tecentriq in NSCLC
20.05.Pharmacists should have greater powers to ensure meds access, says RPS
20.05.UK's coronavirus testing capacity has been 'inadequate', Committee finds
18.05.New COVID-10 guidelines for CKD and interstitial lung disease
18.05.ViiV HIV prevention trial stopped early on efficacy
18.05.AstraZeneca/Daiichi Sankyo's Enhertu picks up third breakthrough designation
18.05.Gov't streams £84m into UK COVID-19 vaccines research
15.05.Roche launches new blood gas digital solution
15.05.Exvastat wins 3.6m euro grant for COVID-19 trial
15.05.A&E visits hit lowest level on record
15.05.EU regulators approve Takeda's Adcetris for sALCL
14.05.FDA refuse to file BMS/bluebird bio's CAR-T therapy